Literature DB >> 27122686

Cardiac Remodeling, Adaptations and Associated Myocardial Mechanics in Hypertensive Heart Diseases.

Yau-Huei Lai1, Chi-In Lo1, Yih-Jer Wu2, Chung-Lieh Hung3, Hung-I Yeh2.   

Abstract

UNLABELLED: Hypertension is the leading cause of heart failure and cardiovascular comorbidities in developed countries. Left ventricular structural/functional alterations such as concentric remodeling or hypertrophy have been extensively studied in hypertensive heart diseases. Furthermore, it is also well-recognized that diastolic function actually deteriorates in hypertensive subjects prior to overt heart failure. Novel imaging modality techniques such as myocardial deformation have allowed for early detection of regional/global myocardial contractile dysfunction. Myocardial deformation, which can be quantified by measuring the systolic strain and strain rate in three different directions (longitudinal, circumferential and radial), has facilitated new insights into the understanding of cardiac systolic mechanics in subjects with early stage myocardial damage. Previous studies had shown that longitudinal function remains the most sensitive parameter in identifying hypertension-related myocardial dysfunction, particularly for those patients who had developed LV hypertrophy. Instead, preserved or enhanced short-axis function, when presented as circumferential or radial strains, may remain relatively preserved or enhanced in order to compensate for longitudinal functional decline. In this manner, global cardiac pumping in terms of ejection fraction may remain relatively unchanged. The early recognition of subclinical systolic dysfunction and associated mechanical compensation in the context of hypertension is crucial, which potentially helps to identify a disease stage that is still responsive to therapeutic intervention. KEY WORDS: Concentric remodeling; Hypertension; Myocardial mechanics; Strain; Subclinical systolic dysfunction.

Entities:  

Year:  2013        PMID: 27122686      PMCID: PMC4804962     

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  55 in total

Review 1.  Echocardiographic assessment of myocardial strain.

Authors:  John Gorcsan; Hidekazu Tanaka
Journal:  J Am Coll Cardiol       Date:  2011-09-27       Impact factor: 24.094

2.  Impaired subendocardial contractile myofiber function in asymptomatic aged humans, as detected using MRI.

Authors:  Joost Lumens; Tammo Delhaas; Theo Arts; Brett R Cowan; Alistair A Young
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-05-05       Impact factor: 4.733

Review 3.  Role of tissue Doppler and strain echocardiography in current clinical practice.

Authors:  Theodore P Abraham; Veronica L Dimaano; Hsin-Yueh Liang
Journal:  Circulation       Date:  2007-11-27       Impact factor: 29.690

4.  2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.

Authors:  Mariell Jessup; William T Abraham; Donald E Casey; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Marvin A Konstam; Donna M Mancini; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy
Journal:  Circulation       Date:  2009-03-26       Impact factor: 29.690

5.  Coupled systolic-ventricular and vascular stiffening with age: implications for pressure regulation and cardiac reserve in the elderly.

Authors:  C H Chen; M Nakayama; E Nevo; B J Fetics; W L Maughan; D A Kass
Journal:  J Am Coll Cardiol       Date:  1998-11       Impact factor: 24.094

6.  Pulse pressure compared with other blood pressure indexes in the prediction of 25-year cardiovascular and all-cause mortality rates: The Chicago Heart Association Detection Project in Industry Study.

Authors:  K Miura; A R Dyer; P Greenland; M L Daviglus; M Hill; K Liu; D B Garside; J Stamler
Journal:  Hypertension       Date:  2001-08       Impact factor: 10.190

Review 7.  Treatment of heart failure with normal ejection fraction: an inconvenient truth!

Authors:  Walter J Paulus; Joris J M van Ballegoij
Journal:  J Am Coll Cardiol       Date:  2010-02-09       Impact factor: 24.094

8.  Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction.

Authors:  Nazha Hamdani; Kalkidan G Bishu; Marion von Frieling-Salewsky; Margaret M Redfield; Wolfgang A Linke
Journal:  Cardiovasc Res       Date:  2012-12-04       Impact factor: 10.787

Review 9.  Hypertension and diastolic heart failure.

Authors:  Alan H Gradman; J Travis Wilson
Journal:  Curr Cardiol Rep       Date:  2009-11       Impact factor: 2.931

10.  Cardiac mechanics in mild hypertensive heart disease: a speckle-strain imaging study.

Authors:  Arumugam Narayanan; Gerard P Aurigemma; Marcello Chinali; Jeffrey C Hill; Theo E Meyer; Dennis A Tighe
Journal:  Circ Cardiovasc Imaging       Date:  2009-07-21       Impact factor: 7.792

View more
  3 in total

1.  The Incremental Effect of Obesity on Myocardial Fibrosis In Patients with Aortic Stenosis.

Authors:  Se-Jung Yoon
Journal:  J Cardiovasc Ultrasound       Date:  2016-12-28

2.  Subclinical markers of cardiovascular disease predict adverse outcomes in chronic kidney disease patients with normal left ventricular ejection fraction.

Authors:  Samir Sulemane; Vasileios F Panoulas; Athanasios Bratsas; Julia Grapsa; Edwina A Brown; Petros Nihoyannopoulos
Journal:  Int J Cardiovasc Imaging       Date:  2017-01-24       Impact factor: 2.357

3.  Subclinical Compromise in Cardiac Strain Relates to Lower Cognitive Performances in Older Adults.

Authors:  Hailey A Kresge; Omair A Khan; Madison A Wagener; Dandan Liu; James G Terry; Sangeeta Nair; Francis E Cambronero; Katherine A Gifford; Katie E Osborn; Timothy J Hohman; Kimberly R Pechman; Susan P Bell; Thomas J Wang; John Jeffrey Carr; Angela L Jefferson
Journal:  J Am Heart Assoc       Date:  2018-02-13       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.